Aethlon Medical Files to Sell Common Stock, Warrants
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Aethlon Medical, Lowers Price Target to $10
HC Wainwright & Co. analyst Vernon Bernardino maintains Aethlon Medical (NASDAQ:AEMD) with a Buy and lowers the price target from $23 to $10.
Aethlon Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/04/2024 443.48% HC Wainwright & Co. $23 → $10 Maintains Buy 10/24/2023 1150% HC Wainwright & Co. $90 →
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)
Aethlon Medical Explores Synergies With Santersus Devices
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious...
Maxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)
Earnings Call: Aethlon Medical Q3 FY2024 Results and Trials Update
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript
Earnings Call Summary | Aethlon Medical(AEMD.US) Q3 2024 Earnings Conference
The following is a summary of the Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript:Financial Performance:Aethlon Medical had a cash balance of approximately $8 million as of December 31,
Aethlon Medical GAAP EPS of -$1.37 In-line
Recap: Aethlon Medical Q3 Earnings
Aethlon Medical (NASDAQ:AEMD) reported its Q3 earnings results on Wednesday, February 14, 2024 at 04:15 PM.Here's what investors need to know about the announcement.EarningsAethlon Medical missed esti
Aethlon Medical Q3 EPS $(1.37) Misses $(1.23) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(1.23) by 11.38 percent. This is a 14.17 percent decrease over losses of $(
Aethlon Medical 3Q Loss/Shr $1.37 >AEMD
Aethlon Medical 3Q Loss/Shr $1.37 >AEMD
Press Release: Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, Feb. 14, 2024 Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO, Feb.
Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. • CAE (NYSE:CAE) is estimated to report quarterl
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) shares rose 23.1% to $1.49 during Monday's pre-market session. The market value of their outstanding shares is at $21.4 million. 60 Degrees (NASDAQ:SXTP) stock moved
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTelesis Bio (NASDAQ:TBIO) shares moved upwards by 32.5% to $0.53 during Friday's pre-market session. The company's market cap stands at $15.8 million. Femasys (NASDAQ:FEMY) shares increased by
No Data